Latest News
Spruce Capital Partners and Xeraya Capital have held the first close of MLS Capital Fund II, LP at USD150 million.
MLS Capital Fund II, the successor to the USD162 million Malaysian Life Sciences Capital Fund, is co-managed by Spruce Capital Partners and Xeraya Capital, which will invest the funds in a diversified portfolio of biogreentech companies at all stages of development.
Biogreentech spans plant and animal agriculture; food, feed, and nutrition; bio-renewable chemicals and materials; and adjacent opportunities along the value chain, including "big data analytics," robotics, production, harvesting and use of natural resources, and synthetic biology.
"The use of
Kayne Partners the private equity group of Kayne Anderson Capital Advisors, has invested in Drivewyze to support the growth of its mobile-based weigh station bypass business for the trucking industry.
Headquartered in Edmonton, Alberta, with offices in Burlingame, California, Drivewyze helps commercial trucking companies save time and money by allowing their trucks to bypass weigh stations based on the strength of their safety records. Founded in 2003 by transportation technology experts Brian Heath (Chief Executive Officer) and Fred Ko (VP of Operations), IIS is a privately held company that develops solutions to improve transportation safety and efficiency for governments, businesses
Baker Botts, an international business law firm, advised clients on over 35 major M&A transactions (including spin-offs and split-offs) valued at nearly USD200 billion in the second half of 2014.
When combined with M&A deal volume and value from the first half of the year (38 deals for a total value of USD56.6 billion), Baker Botts’ totals exceeded USD250 billion, representing a 233% increase over 2013.
“Large energy transactions continued to lead the way in 2014,” says David Kirkland, Co-Chair of Baker Botts's Corporate Department.
“While deal volume increased, deal size is what really drove M&A totals to much higher
2014 represented the highest ever aggregate exit value for private equity buyout fund managers, with a total of 1,604 exits globally valued at USD428bn, according to Preqin.
This is up over 30% on the total value of exits in 2013, and is the highest ever annual value of private equity-backed buyout exits. This has resulted in a significant increase in the level of capital being returned to buyout fund investors, which had almost surpassed the full-year 2013 amount as of June 2014 (the latest data available). The total value of deals in 2014 reached USD332bn globally, the highest annual amount
Intralinks DealNexus has partnered with PEI Services (PEI) in order to enhance its database of private equity portfolio companies.
DealNexus is one of the leading online deal sourcing and marketing platforms for M&A professionals. The partnership expands upon the high quality data already within the platform. This will enhance Intralinks DealNexus’ proprietary matching capabilities, providing a more robust, content driven platform that creates a destination for dealmakers.
The Intralinks DealNexus platform has seen tremendous growth this past year, with 46 per cent annual growth in member firm count and 96 per cent growth in unique members from year-end 2013
Newly-launched private equity firm Delos Capital has acquired FCA Packaging (FCA) from a group of private investors.
One of FCA’s founders as well as senior management partnered Delos in the transaction.
FCA is a manufacturer of customised and engineered packaging products and solutions for major original equipment manufacturers serving such industries as non-residential construction, heavy duty engines, agriculture, mining and energy.
“Delos is excited to partner with the FCA management team for the next stage of the Company’s growth,” says Matthew Constantino, managing partner of Delos. “FCA has a long history being a best-in-class provider of comprehensive packaging solutions to
SK Capital Partners has completed a controlling strategic investment in Halo Pharmaceutical, a premier provider of outsourced development and manufacturing services to the pharmaceutical industry.
The strategic investment is consistent with SK Capital’s sector-focused strategy of investing in niche market leaders with strong brands and technologies and actively supporting management in building thriving businesses with sustainable competitive advantages.
“By having SK Capital as our partner, Halo will have the resources to acquire strategic assets that will increase our dosage forms offerings, formulation technologies, and enable superior customer service as a one-stop source for formulation development through commercialisation.”
Halo Pharmaceutical is
The amount of capital invested by venture capital fund managers in young companies reached USD87bn in 2014, over 58% more than the capital invested in 2013. Preqin’s Head of Private Equity Products, Christopher Elvin (pictured), analyses the latest data:
Over the past year, a total of 7,474 venture capital financings were announced globally with an aggregate value of USD86.6bn. This represents an 11% fall in the number of financings taking place compared to 2013, but a 58% rise in the aggregate value of deals compared to the previous year.
*Figures exclude add-ons, grants, mergers, venture debt and secondary stock purchases
Rock Hill Capital Group has completed a majority recapitalisation of JP Hydro (JP Services), a provider of industrial integrity testing services along the Gulf Coast and throughout Texas.
JP Services is led by Founder and CEO, Justin Peter, and is headquartered in The Woodlands, Texas. The Company provides hydrostatic and pneumatic testing, and torqueing and pigging services to its energy and industrial clients throughout the southeastern United States. JP Services is primarily focused on servicing three industrial segments – both new and existing pipelines, tanks and facilities.
“We’ve been looking for a midstream services platform and management team to invest
Periscope Equity a Chicago-based private equity firm is to make a significant investment in Strategic Pharma Solutions LLC (SPS) a Raleigh-based healthcare communications agency.
Founded in 2007 Strategic Pharma Solutions tailors communications solutions for pharmaceutical medical device and biotechnology companies across the United States through its digital scientific and creative offerings. The agency also specializes in brand strategy and market development for products coming to market or currently on the market.
Since its inception Strategic Pharma Solutions has seen an 80 percent increase in staff tripled its client base and doubled its revenue. Periscope Equity's investment will help Strategic Pharma
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
